Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer

Stopped early · Not applicable

Conditions studied: Breast Cancer

In brief

This research study is comparing Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) to MRI as a screening tool for breast cancer.

Key facts

Study ID

NCT02275871

Run by

Beth Israel Deaconess Medical Center

People needed

44

Starts

2014-11-01

Expected to finish

2020-01-01

Last updated by the study team

2020-03-16

Who can join

Age: 30 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women
• Age > or equal to 30 years
• High risk (>20% lifetime risk)
• Has a bilateral mammogram within the last 7 months
• Has had a same day high risk screening MRI

You may not qualify if…

• Participants who have a known allergy or contraindication to iodinated contrast.
• Participants who have a known allergy to food or medications.
• Participants who have renal insufficiency or failure.
• Participants who are pregnant or breastfeeding.
• Participants with a concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.